TLDR Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.
The document discusses the role of small-molecule drugs that target Androgen Receptors (AR) in treating various androgen-related disorders, particularly prostate cancer. The AR is a protein that plays a crucial role in male sexual maturation and functionality, and its dysregulation is associated with diseases like prostate cancer and androgenic alopecia. Drugs like Bicalutamide and Enzalutamide, which target AR, have shown significant clinical efficacy in improving survival and quality of life in patients with advanced prostate cancer. Other drugs like Apalutamide and Darolutamide have also been developed and clinically approved, showing similar efficacy. Additionally, drugs like finasteride and dutasteride, which inhibit the enzyme 5-alpha-reductase, have shown potential in treating other androgen-related disorders. The document concludes that continued research in this field could lead to the discovery of more effective drugs targeting AR, improving patient outcomes and expanding therapeutic options.
32 citations,
September 2018 in “Clinical Obstetrics and Gynecology” Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.
52 citations,
April 2008 in “Therapeutics and clinical risk management” The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.
42 citations,
May 2003 in “Mini-reviews in Medicinal Chemistry” New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.
204 citations,
February 2000 in “Current Medicinal Chemistry” Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.
49 citations,
January 1994 in “The Journal of Steroid Biochemistry and Molecular Biology” RU 58841 may treat acne, hair loss, and excessive hair growth.
29 citations,
October 1988 in “Journal of Steroid Biochemistry” Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.
2 citations,
November 2017 in “Elsevier eBooks” Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.
6 citations,
December 2020 in “Dermatological reviews” COVID-19 may worsen with androgens; anti-androgen drugs could help.
17 citations,
January 2015 in “MedChemComm” New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.
50 citations,
July 2021 in “Nature Communications” The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.
68 citations,
April 2014 in “Journal of Molecular Endocrinology” The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.
